Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.6M Buy
390,082
+136,267
+54% +$34M 0.04% 446
2025
Q4
$61.1M Buy
253,815
+112,120
+79% +$28.7M 0.03% 566
2025
Q3
$38.8M Buy
141,695
+8,810
+7% +$2.41M 0.02% 742
2025
Q2
$34.3M Sell
132,885
-7,421
-5% -$1.77M 0.02% 722
2025
Q1
$31.4M Buy
140,306
+44,144
+46% +$10.3M 0.02% 760
2024
Q4
$22M Sell
96,162
-12,731
-12% -$3.07M 0.01% 909
2024
Q3
$26.6M Sell
108,893
-2,987
-3% -$667K 0.02% 804
2024
Q2
$21.4M Buy
111,880
+13,322
+14% +$2.7M 0.01% 852
2024
Q1
$19.5M Buy
98,558
+24,286
+33% +$4.45M 0.01% 888
2023
Q4
$12.8M Buy
74,272
+3,852
+5% +$592K 0.01% 1094
2023
Q3
$10.4M Sell
70,420
-10,135
-13% -$1.83M 0.01% 1083
2023
Q2
$17.6M Buy
80,555
+5,774
+8% +$1.29M 0.01% 887
2023
Q1
$16.4M Sell
74,781
-43,946
-37% -$9.53M 0.01% 915
2022
Q4
$24.7M Buy
118,727
+22,645
+24% +$4.98M 0.02% 700
2022
Q3
$21M Buy
96,082
+10,199
+12% +$2.32M 0.02% 765
2022
Q2
$18M Sell
85,883
-17,767
-17% -$3.78M 0.01% 854
2022
Q1
$25.1M Sell
103,650
-75,753
-42% -$18.3M 0.02% 828
2021
Q4
$46.7M Sell
179,403
-13,980
-7% -$3.63M 0.03% 585
2021
Q3
$51M Buy
193,383
+7,485
+4% +$2.05M 0.03% 524
2021
Q2
$45.8M Sell
185,898
-38,346
-17% -$8.06M 0.03% 563
2021
Q1
$43.5M Buy
224,244
+7,659
+4% +$1.54M 0.03% 554
2020
Q4
$46M Buy
216,585
+17,226
+9% +$3.43M 0.03% 579
2020
Q3
$34.2M Buy
199,359
+18,142
+10% +$3.35M 0.02% 632
2020
Q2
$34.8M Buy
181,217
+31,461
+21% +$5.15M 0.03% 538
2020
Q1
$22.1M Sell
149,756
-12,179
-8% -$1.94M 0.02% 685
2019
Q4
$25.1M Buy
161,935
+29,965
+23% +$4.32M 0.02% 837
2019
Q3
$17.8M Buy
131,970
+11,033
+9% +$1.45M 0.01% 982
2019
Q2
$14.8M Sell
120,937
-11,481
-9% -$1.27M 0.01% 1123
2019
Q1
$13.8M Buy
132,418
+35,364
+36% +$3.65M 0.01% 1055
2018
Q4
$11.1M Buy
97,054
+51,411
+113% +$5.51M 0.01% 1191
2018
Q3
$5.26M Sell
45,643
-317
-0.7% -$34.7K ﹤0.01% 1817
2018
Q2
$4.76M Buy
45,960
+1,334
+3% +$135K ﹤0.01% 1879
2018
Q1
$4.39M Buy
44,626
+36,969
+483% +$3.49M ﹤0.01% 1880
2017
Q4
$649K Sell
7,657
-35,081
-82% -$2.9M ﹤0.01% 3820
2017
Q3
$3.29M Buy
42,738
+23,981
+128% +$1.83M ﹤0.01% 2144
2017
Q2
$1.46M Buy
18,757
+15,048
+406% +$1.08M ﹤0.01% 2918
2017
Q1
$267K Sell
3,709
-5,081
-58% -$351K ﹤0.01% 4420
2016
Q4
$545K Sell
8,790
-56,282
-86% -$3.45M ﹤0.01% 4285
2016
Q3
$4.22M Buy
65,072
+63,500
+4,039% +$4.23M ﹤0.01% 1818
2016
Q2
$100K Buy
1,572
+43
+3% +$2.54K ﹤0.01% 5070
2016
Q1
$89K Buy
1,529
+139
+10% +$7.87K ﹤0.01% 5739
2015
Q4
$74K Sell
1,390
-5
-0.4% -$282 ﹤0.01% 5628
2015
Q3
$72K Sell
1,395
-20,220
-94% -$1.09M ﹤0.01% 5190
2015
Q2
$1.22M Buy
21,615
+3,271
+18% +$206K ﹤0.01% 3003
2015
Q1
$1.32M Buy
18,344
+16,162
+741% +$1.05M ﹤0.01% 2855
2014
Q4
$122K Sell
2,182
-503
-19% -$26.3K ﹤0.01% 5088
2014
Q3
$132K Sell
2,685
-55
-2% -$2.8K ﹤0.01% 4531
2014
Q2
$138K Buy
2,740
+723
+36% +$35.8K ﹤0.01% 4427
2014
Q1
$90K Sell
2,017
-1,058,750
-100% -$47.6M ﹤0.01% 5090
2013
Q4
$49.9M Buy
1,060,767
+1,048,266
+8,385% +$53.1M 0.05% 369
2013
Q3
$659K Sell
12,501
-12,392
-50% -$601K ﹤0.01% 3231
2013
Q2
$1.12M Buy
+24,893
New +$1.18M ﹤0.01% 2804

Other funds holding RMD

Citigroup's RMD Position: Q1 2026 in Review

Citigroup increased its ResMed (RMD) stake by 54% in Q1 2026, buying an estimated $34M and bringing the position to 390,082 shares worth $87.6M. The position accounts for 0.04% of the portfolio, ranked #446.

Citigroup first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Citigroup held 390,082 shares of ResMed worth $87.6M as of Q1 2026.
  • Citigroup bought 136,267 ResMed shares in Q1 2026, an estimated $34M.
  • ResMed made up 0.04% of Citigroup's portfolio in Q1 2026, its #446 holding.
  • Citigroup first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.